Ron Muhlenkamp - Muhlenkamp & Company
Holding/activity history for Bristol-Myers Squibb Co. (BMY)
← All BMY superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q2 | 0 | 0.00 | Sell 100.00% | 2.13 | $39.35–51.19 · VW $46.83i | SEC | |
| 2024 Q1 | 135,045 | 2.13 | Add 2.49% | 0.05 | $39.91–55.04 · VW $45.35i | $7,323,490 | SEC |
| 2023 Q4 | 131,760 | 2.21 | Add 1.56% | 0.03 | $47.58–53.48 · VW $50.60i | $6,760,606 | SEC |
| 2023 Q3 | 129,732 | 2.60 | Add 0.13% | <0.01 | $48.25–62.40 · VW $53.34i | $7,529,645 | SEC |
| 2023 Q2 | 129,569 | 2.94 | $63.95 | $8,285,938 | SEC |
Price snapshot:
Current price$59.34
52-week low$40.99
52-week high$61.55